Patent · US Active

Substituted pyridines, pyridazines, pyrimidines, and 1,2,4-triazines as TYK2 inhibitors

US11613548B2 · kind B2 · utility

1Cited by
51References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 5, 2022
Grant dateMar 28, 2023
Priority date
Expiry dateMay 5, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Described herein are compounds of Formula (XVII) that are TYK2 inhibitors, methods of making such compounds, pharmaceutical compositions and medicaments comprising such compounds, and methods of Using such compounds in the treatment of conditions, diseases, or disorders that would benefit from modulation of TYK2 activity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.